MENU
TENX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tenax Therapeutics (TENX) Earnings Date & Reports
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension... Show more
Industry: #Medical Specialties
A.I. Advisor
published Earnings
TENX is expected to report earnings to rise 2.86% to -36 cents per share on November 18
Q3'26
Est.
$-0.36
Q2'26
Beat
by $0.03
Q1'26
Missed
by $0.12
Q4'25
Missed
by $0.15
Q3'25
Missed
by $0.17
The last earnings report on July 31 showed earnings per share of -34 cents, beating the estimate of -38 cents. With 1.46M shares outstanding, the current market capitalization sits at 69.23M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of novel therapeutic products
Industry Biotechnology
Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
16
Web
https://www.tenaxthera.com